Results 251 to 260 of about 822,808 (285)

Altered colonic microflora and its metabolic profile in mice with acute viral myocarditis induced by coxsackievirus B3. [PDF]

Virol J
Xue Y, Lin S, Chen M, Ke J, Zhang J, Fan Q, Chen Y, Chen F.   +7 more
europepmc   +1 more source

Cardiac Inflammation Based on Multi-modality Imaging and Its Relation to Viraemia and Systemic Inflammation in Viral Myocarditis

Florence Mouy, Kevin Horn, Sudhir Vinayak, Khalid Makhdomi, Kevin Ombati, Ahmed El‐Medany, Rachel Scott, Mariah Obino, Edward Nganga, Michael H. Chung, Anoop Shah, Stephen R. Bowen, Samuel Gitau, Shirjel Alam   +13 more
openalex   +1 more source

Viral myocarditis in combination with genetic cardiomyopathy as a cause of sudden death. An autopsy series. [PDF]

BMC Cardiovasc Disord
Callon D, Joanne P, Andreoletti L, Agbulut O, Chevalier P, Fornès P.   +5 more
europepmc   +1 more source

Authors' response to: How to manage ventricular arrhythmia in patients with viral myocarditis. [PDF]

Eur Heart J Open
Villatore A, Peretto G.
europepmc   +1 more source

How to manage ventricular arrhythmia in patients with viral myocarditis. [PDF]

Eur Heart J Open
Kataoka N, Imamura T.
europepmc   +1 more source

On the trail of a new virus. The Calvert Lecture 1997. [PDF]

, 1998
Kerr, JR
core   +1 more source

Viral Myocarditis as a Factor Leading to the Development of Heart Failure Symptoms, Including the Role of Parvovirus B19 Infection-Systematic Review. [PDF]

Int J Mol Sci
Krych S, Jęczmyk A, Jurkiewicz M, Żurek M, Jekiełek M, Kowalczyk P, Kramkowski K, Hrapkowicz T.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Viral Myocarditis-Incidence, Diagnosis and Management.

Journal of Cardiothoracic and Vascular Anesthesia, 2020
Viral myocarditis has an incidence rate of 10 to 22 per 100,000 individuals. The presentation pattern of viral myocarditis can range from nonspecific symptoms of fatigue and shortness of breath to more aggressive symptoms that mimic acute coronary ...
M. Olejniczak, M. Schwartz, E. Webber, A. Shaffer, Tjorvi E Perry   +4 more
semanticscholar   +1 more source

Multitargeted Immunomodulatory Therapy for Viral Myocarditis by Engineered Extracellular Vesicles.

ACS Nano
Immune regulation therapies are considered promising for treating classically activated macrophage (M1)-driven viral myocarditis (VM). Alternatively, activated macrophage (M2)-derived extracellular vesicles (M2 EVs) have great immunomodulatory potential ...
W. Pei, Yingying Zhang, Xiao-long Zhu, Chen Zhao, Xueqin Li, Hezuo Lü, Kun Lv   +6 more
semanticscholar   +1 more source